Pre-existing renal failure worsens the outcome after intestinal ischaemia and reperfusion in rats

Nephrology Dialysis Transplantation

Volumn 25, Issue 11, 2010, Pages 3509-3517

  Skott, Martin ^a   Nørregaard, Rikke ^a   Sorensen, Hanne Birke ^b   Kwon, Tae Hwan ^c   Frøkiaer, Jørgen ^a   Nielsen, Søren ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c Kyungpook National University School of Medicine   (South Korea)

Author keywords

Acute kidney injury; Intestinal ischaemia; Intestinal reperfusion; Multiple organ failure; Pre existing renal failure

Indexed keywords

ALBUMIN; CREATININE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; POTASSIUM; SODIUM; UREA; WATER; ACUTE PHASE PROTEIN; LIPOCALIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN PROTEIN, RAT; NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN PROTEIN, RAT; ONCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAGE; CLAMP; CONTROLLED STUDY; DISEASE MODEL; FLUID INTAKE; INTESTINE ISCHEMIA; INTESTINE REPERFUSION; KIDNEY FAILURE; KIDNEY FUNCTION; MALE; MEAN ARTERIAL PRESSURE; MORBIDITY; MORTALITY; MULTIPLE ORGAN FAILURE; NEPHRECTOMY; NONHUMAN; POLYDIPSIA; POLYURIA; PRIORITY JOURNAL; PROTEINURIA; RAT; REPERFUSION; REPERFUSION INJURY; SUPERIOR MESENTERIC ARTERY; SURVIVAL RATE; UREMIA; URINARY EXCRETION; URINE VOLUME; ACUTE KIDNEY FAILURE; ANIMAL; BLOOD PRESSURE; CHRONIC DISEASE; HEART RATE; INTESTINE; ISCHEMIA; KIDNEY DISEASE; URINE; VASCULARIZATION;

ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; ANIMALS; BLOOD PRESSURE; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; HEART RATE; INTESTINES; ISCHEMIA; KIDNEY DISEASES; LIPOCALINS; MALE; MULTIPLE ORGAN FAILURE; NEPHRECTOMY; PROTO-ONCOGENE PROTEINS; RATS; REPERFUSION INJURY;

EID: 79952199281     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq281     Document Type: Article

References (45)

1. Porter GA. Risk factors for toxic nephropathies. Toxicol Lett 1989; 46: 269-279 (Pubitemid 19084020)
2. Bonventre JV. Pathophysiology of acute kidney injury: Roles of potential inhibitors of inflammation. Contrib Nephrol 2007; 156: 39-46
3. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 2002; 39: 930-936 (Pubitemid 34454211)
4. Hsu CY, Ordonez JD, Chertow GM et al. The risk of acute renal failure in patients with chronic kidney disease. Kidney Int 2008; 74: 101-107 (Pubitemid 351841887)
5. Hsu C-y, Chertow GM, McCulloch CE et al. Nonrecovery of kidney function and death after acute on chronic renal failure. Clin J Am Soc Nephrol 2009; 4: 891-898
6. Khosla N, Soroko SB, Chertow GM et al. Preexisting chronic kidney disease: A potential for improved outcomes from acute kidney injury. Clin J Am Soc Nephrol 2009; 4: 1914-1919
7. Prescott GJ, Metcalfe W, Baharani J et al. A prospective national study of acute renal failure treated with RRT: Incidence, aetiology and outcomes. Nephrol Dial Transplant 2007; 22: 2513-2519 (Pubitemid 47365514)
8. Brar H, Olivier J, Lebrun C et al. Predictors of mortality in a cohort of intensive care unit patients with acute renal failure receiving continuous renal replacement therapy. Am J Med Sci 2008; 335: 342-347
9. Ishani A, Xue JL, Himmelfarb J et al. Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol 2009; 20: 223-228
10. Coresh J, Selvin E, Stevens LA et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047 (Pubitemid 350074801)
11. Hallan SI, Coresh J, Astor BC et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol 2006; 17: 2275-2284 (Pubitemid 44141918)
12. Stevens PE, O'Donoghue DJ, de Lusignan S et al. Chronic kidney disease management in the United Kingdom: NEOERICA project results. Kidney Int 2007; 72: 92-99 (Pubitemid 47014451)
13. Manhes G, Heng AE, Aublet-Cuvelier B et al. Clinical features and outcome of chronic dialysis patients admitted to an intensive care unit. Nephrol Dial Transplant 2005; 20: 1127-1133 (Pubitemid 40862101)
14. Ruggenenti P, Schieppati A, Remuzzi G. Progression, remission, regression of chronic renal diseases. Lancet 2001; 357: 1601-1608 (Pubitemid 32488830)
15. Farrington K, Hodsman A, Casula A et al. UK Renal Registry 11th Annual Report (December 2008): Chapter 4 ESRD prevalent rates in 2007 in the UK: National and centre-specific analyses. Nephron Clin Pract 2009; 111: C43-c68
16. Kuitunen A, Vento A, Suojaranta-Ylinen R et al. Acute renal failure after cardiac surgery: Evaluation of the RIFLE classification. Ann Thorac Surg 2006; 81: 542-546 (Pubitemid 43120552)
17. Del Duca D, Iqbal S, Rahme E et al. Renal failure after cardiac surgery: Timing of cardiac catheterization and other perioperative risk factors. Ann Thorac Surg 2007; 84: 1264-1271 (Pubitemid 47417882)
18. Griffin K, Picken M, Bidani A. Method of renal mass reduction is a critical modulator of subsequent hypertension and glomerular injury. J Am Soc Nephrol 1994; 4: 2023-2031 (Pubitemid 24977009)
19. Floege J, Alpers CE, Burns MWet al. Glomerular cells, extracellular matrix accumulation, and the development of glomerulosclerosis in the remnant kidney model. Lab Invest 1992; 66: 485-497
20. Kliem V, Johnson RJ, Alpers CE et al. Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats. Kidney Int 1996; 49: 666-678 (Pubitemid 26093075)
21. Quiroz Y, Ferrebuz A, Vaziri ND et al. Effect of chronic antioxidant therapy with superoxide dismutase-mimetic drug, tempol, on progression of renal disease in rats with renal mass reduction. Nephron Exp Nephrol 2009; 112: E31-e42
22. Song J, Meng L, Li S et al. A combination of Chinese herbs, Astragalus membranaceus var. mongholicus and Angelica sinensis, improved renal microvascular insufficiency in 5/6 nephrectomized rats. Vascul Pharmacol 50: 185-193
23. Moore FA. The role of the gastrointestinal tract in postinjury multiple organ failure. Am J Surg 1999; 178: 449-453 (Pubitemid 30058289)
24. Moore EE, Moore FA, Franciose RJ et al. The postischemic gut serves as a priming bed for circulating neutrophils that provoke multiple organ failure. J Trauma 1994; 37: 881-887
25. Zhao X, Town JR, Yang A et al. A novel ELR-CXC chemokine antagonist reduces intestinal ischemia reperfusion-induced mortality, and local and remote organ injury. J Surg Res in press, corrected proof
26. Caty MG, Guice KS, Oldham KT et al. Evidence for tumor necrosis factor-induced pulmonary microvascular injury after intestinal ischemia- reperfusion injury. Ann Surg 1990; 212: 694-700
27. Grotz MR, Deitch EA, Ding J et al. Intestinal cytokine response after gut ischemia: Role of gut barrier failure. Ann Surg 1999; 229: 478-486 (Pubitemid 30191744)
28. Rothenbach P, Turnage RH, Iglesias J et al. Downstream effects of splanchnic ischemia-reperfusion injury on renal function and eicosanoid release. J Appl Physiol 1997; 83: 530-536 (Pubitemid 27332770)
29. Greca FH, Goncalves NM, Souza Filho ZA et al. The protective effect of methylene blue in lungs, small bowel and kidney after intestinal ischemia and reperfusion. Acta Cir Bras 2008; 23: 149-156 (Pubitemid 351488607)
30. LaNoue JL Jr, Turnage RH, Kadesky KM et al. The effect of intestinal reperfusion on renal function and perfusion. J Surg Res 1996; 64: 19-25 (Pubitemid 26268723)
31. Mutlu G, Abbasoglu L, Dogru-Abbasoglu S et al. Morphologic changes and lipid peroxidation in renal tissues of young rats following intestinal ischemia-reperfusion. Pediatr Surg Int 2002; 18: 337-340 (Pubitemid 41184144)
32. Kwon TH, Frokiaer J, Knepper MA et al. Reduced AQP1, -2, and -3 levels in kidneys of rats with CRF induced by surgical reduction in renal mass. Am J Physiol 1998; 275: F724-F741
33. Doi K, Leelahavanichkul A, Hu X et al. Pre-existing renal disease promotes sepsis-induced acute kidney injury and worsens outcome. 2008; 74: 1017-1025
34. Kaufman J, Siegel N, Hayslett J. Functional and hemodynamic adaptation to progressive renal ablation. Circ Res 1975; 36: 286-293
35. Carden DL, Granger DN. Pathophysiology of ischaemia-reperfusion injury. J Pathol 2000; 190: 255-266 (Pubitemid 30141372)
36. Gibot S, Massin F, Alauzet C et al. Effects of the TREM-1 pathway modulation during mesenteric ischemia-reperfusion in rats. Crit Care Med 2008; 36: 504-510 (Pubitemid 351158626)
37. Swank GM, Deitch EA. Role of the gut in multiple organ failure: Bacterial translocation and permeability changes. World J Surg 1996; 20: 411-417 (Pubitemid 26138587)
38. Bolignano D, Lacquaniti A, Coppolino G et al. Neutrophil gelatinase- associated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol 2009; 4: 337-344
39. Bolignano D, Donato V, Coppolino G et al. Neutrophil gelatinase- associated lipocalin (NGAL) as a marker of kidney damage. Am J Kidney Dis 2008; 52: 595-605
40. Mishra J, Ma Q, Prada A et al. Identification of neutrophil gelatinaseassociated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 2003; 14: 2534-2543 (Pubitemid 37169339)
41. Mori K, Nakao K. Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage. Kidney Int 2007; 71: 967-970 (Pubitemid 46741985)
42. Ichino M, Kuroyanagi Y, Kusaka M et al. Increased urinary neutrophil gelatinase associated lipocalin levels in a rat model of upper urinary tract infection. J Urol 2009; 181: 2326-2331
43. Khanna A, Rossman JE, Fung HL et al. Intestinal and hemodynamic impairment following mesenteric ischemia/reperfusion. J Surg Res 2001; 99: 114-119 (Pubitemid 32613967)
44. Hayward R, Lefer AM. Time course of endothelial-neutrophil interaction in splanchnic artery ischemia-reperfusion. Am J Physiol 1998; 275: H2080-H2086
45. Mozes T, Braquet P, Filep J. Platelet-activating factor: An endogenous mediator of mesenteric ischemia-reperfusion-induced shock. Am J Physiol 1989; 257: R872-R877